Post-mortem genetic testing (cardiac)
Gene-panel analysis of post-mortem tissue (frozen fresh myocardium or paraffin-embedded blocks) targeting ion-channel and cardiomyopathy genes. Recommended in the UK (RCPath inherited cardiac conditions protocol), Australia (NHFA sudden-death guidelines), and internationally for unexplained SCD in individuals under 40 to enable familial cascade screening.